Instant coffee and powdered milk are produced by spray drying. Fraunhofer researchers have adapted this technique to the tricky question of incorporating insoluble substances in core-shell particles. The new method helps reduce the concentration of active ingredients in therapeutic medications.
Encapsulation is used in cosmetics and pharmaceuticals to protect active ingredients against external influences such as aggressive gastric acid. Another use of encapsulation is to control the release of active ingredients inside the body: depending on the permeability of the shell material, the medication is delivered gradually rather than all at once. Because such systems release multiple, smaller doses over an extended period of time, the drug therapy is better tolerated and easier to administer. In some cases, it means taking just one pill a day instead of three.
Insoluble substances are a problem
The first step of the encapsulation process involves dissolving the active ingredient in a liquid medium and mixing it with the shell material. Then the solution is piped to an orifice in the center of a nozzle surrounded by an annular channel through which compressed air is injected at high speed. The pressure disperses the solution into an aerosol of fine droplets, which is then sprayed into a drying cylinder. Here, the liquid evaporates, leaving behind a fine powder of core-shell particles. The problem is that it is difficult to mix insoluble substances with other materials. This limits the choice of shell materials that can be used to produce the particles.
Three-way nozzle permits endless combinations of materials
“For this reason, we use a three-way nozzle to implement spraying. Its advantage is that it permits two substances to be fed separately to the nozzle. The shear forces mix the substances together at the orifice of the nozzle, creating an aerosol containing both materials,” explains Michael Walz, who developed and optimized the new technique with his colleague Dr. Achim Weber at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart.
This system permits endless combinations of materials, enabling the controlled release of active ingredients to be adapted to different applications. “We can modify the particle size and encapsulation efficiency by selecting the appropriate substances and by varying the concentration of the solution, the liquid volume flow, the drying temperature, and the pressure applied to the nozzle. This gives us the capability to respond to almost any customer requirement and develop solutions tailored to their needs,” says Weber.
The new process for the encapsulation of active ingredients could be of interest to fertilizer manufacturers and food processing companies as well as the cosmetics and pharmaceutical industries.
Learn more: Spray drying: Perfect dosing thanks to drug capsules
The Latest on: Drug delivery
[google_news title=”” keyword=”drug delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Vietnam Advanced Dermatology Drug Delivery Devices Market Size, Share, Key Players, Revenue, Demand, and Forecast to 2024 to 2032on May 12, 2024 at 11:33 pm
According to the latest report by Report Ocean, titled this “Vietnam Advanced Dermatology Drug Delivery Devices Market” Report gives evaluation and insights primarily based on authentic consultations ...
- Utahn may be on verge of a significant breakthrough in treating Alzheimer’son May 12, 2024 at 2:00 pm
Still, scientific research takes time and money. With dwindling amounts of both when she came to the University of Utah (Alzheimer’s research isn’t her only iron in the fire), Cross confesses she was ...
- OSU researchers develop device to improve delivery of gene therapy for lung diseaseon May 11, 2024 at 8:28 pm
PORTLAND, Ore. (KTVZ) – Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic ...
- Q&A with the DA: Sentencing in drug crimeson May 11, 2024 at 4:30 am
The information in this special series is for educational purposes only and is not intended to address any particular case, nor should any articles be taken as legal ...
- Embedding Sustainability in Drug Delivery through Industry Consensus at CPHI NAon May 10, 2024 at 12:45 pm
At CPHI NA, Rachel Harris, AstraZeneca, spoke on her work at BioPhorum to enable industry consensus and action for sustainability with drug delivery devices.
- Transdermal Drug Delivery Systems Market Strategies: How to Stay Competitive in 2024-2032on May 9, 2024 at 6:07 pm
Global Transdermal Drug Delivery Systems Market is valued approximately at USD 59.16 billion in 2022 and is anticipated to grow with a growth rate of more than 11.90% over the forecast period ...
- Ocular Drug Delivery Market Updates 2024 : Rise in…on May 9, 2024 at 3:30 am
According to a new report published by Allied Market Research, titled, “Ocular Drug Delivery Market,” The ocular drug delivery market size was valued at $67.7 billion in 2022, and is estimated to ...
- John Patton, Leiter des Kindeva Drug Delivery’s Scientific Advisory Board, zum Gewinner des Charles G. Thiel Preises der RDD Conference ernannton May 8, 2024 at 4:07 pm
John Patton, Leiter des Kindeva Drug Delivery’s Scientific Advisory Board, zum Gewinner des Charles G. Thiel Preises der RDD Conference ernannt ...
- Injectable drug delivery market poised for 8.6% CAGR growth until 2029on May 7, 2024 at 10:26 pm
The market’s revenue is set to reach $1139.4b within the forecast period. Revenue for the global injectable drug delivery market is set to grow by $1139.4b at a compound annual growth rate (CAGR) of 8 ...
- Injectable Drug Delivery Market Worth $1139.4 billion | MarketsandMarkets™on May 6, 2024 at 7:31 am
Injectable Drug Delivery Market in terms of revenue was estimated to be worth $754.5 billion in 2024 and is poised to reach $1139.4 billion by 2029, growing at a CAGR of 8.6% from 2024 to 2029 ...
via Google News and Bing News